https://blog.superhyydl.org/tags/pole/Recent content in POLE on Superhyydl's BlogHugozh-cnSun, 06 Sep 2026 00:00:00 +0000https://blog.superhyydl.org/reading/deficiency-in-pole-exonuclease-causes-synthetic-lethality/Sun, 06 Sep 2026 00:00:00 +0000https://blog.superhyydl.org/reading/deficiency-in-pole-exonuclease-causes-synthetic-lethality/<h2 id="一句话亮点">一句话亮点</h2> <p>本文通过分析近50万例临床肿瘤样本，发现POLE外切酶结构域突变与高度非整倍体呈互斥关系，并验证了POLE外切酶活性是高度非整倍体癌细胞生存所必需、而二倍体细胞不依赖的合成致死靶点。</p> <h2 id="背景痛点">背景/痛点</h2> <p>非整倍体是癌症的普遍特征——超过90%的实体瘤存在染色体数目或结构异常。临床上，高非整倍体负荷与不良预后、免疫治疗耐药密切相关。尽管已知非整倍体诱发蛋白毒性、有丝分裂压力等脆弱性，但靶向这些压力的药物普遍缺乏肿瘤特异性，临床转化困难。</p> <p>那么问题来了：能不能找到只对高非整倍体细胞致命、对正常二倍体细胞无害的靶点？这就是本文的出发点。作者没有从已知通路入手，而是反过来——先看大数据里&quot;什么东西与非整倍体天然互斥&quot;，再从互斥关系中反推合成致死机制。</p> <p><img alt="Fig. 1：Characterization of chromosomal arm–level aneuploidy in the FMI genomic database. A, Pie chart summarizing the FMI genomic database by primary cancer type. MDS, myelodysplastic syndromes. B, Donut charts summarizing the FMI genomic database by chromosome sex, histologic types, metastatic status, and genetic ancestry. C–F, Prevalence of each autosomal chromosome arm loss or gain in carcinoma (C), sarcoma (D), glioma (E), and leukemia (F). G, Distribution of aneuploidy scores in major cancer types (in each boxplot, the center line represents the median value. The lower and upper hinges correspond to the first and third quartiles, respectively, whereas the whiskers extend up to 1.5\x03 the interquartile range. This applies to all the boxplots presented in this study). DLBCL, diffuse large B-cell lymphoma; GIST, gastrointestinal stromal tumor; NHL, non–Hodgkin lymphoma." loading="lazy" src="https://blog.superhyydl.org/images/reading/deficiency-in-pole-exonuclease-causes-synthetic-lethality/figure-01.png"></p>